New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
07:04 EDTNURONeuroMetrix announces initial commercial shipment of SENSUS system
NeuroMetrix has initiated commercial shipment of its SENSUS Pain Management System which received final FDA clearance on November 28, 2012. SENSUS is a transcutaneous electrical nerve stimulator intended for the symptomatic relief and management of chronic intractable pain.
News For NURO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2016
07:08 EDTNURONeuroMetrix says primary initiative for 2016 is launch of Quell
Subscribe for More Information
07:07 EDTNURONeuroMetrix reports Q4 revenue $2.74M, one estimate $2.38M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use